Experts: COVID-19, Departure Of Key FDA Staff Likely Contributing Factors For Delayed AI/ML Action Plan
The recent artificial intelligence/machine learning software action plan released by the US agency took nearly two years to develop.
You may also be interested in...
A new guidance document and a promise to hold a public workshop are just two commitments made by the US agency in a 12 January action plan aimed at AI/ML-based software as a medical device.
US FDA says as artificial intelligence and machine learning offer new opportunities to improve patient care, the agency hopes to encourage innovation by developing a draft guidance on the issue for sponsors. It also released a discussion paper outlining key issues it wants feedback on from industry and other key stakeholders.
A former Army ranger, Michael Minogue wants to help military veterans transition into and gain employment opportunities in the medtech industry.